Although the presence of some rare side effects and optimal approaches of OT application remain to be clarified, the perspective to reduce the morbidity and mortality of atherosclerosis and CAD by targeting OTR signaling is highly desirable, which can at least avoid the compromising effect of VP receptor signaling while efficiently blocking the key pathological link in CAD development. The gene discussed is OXTR; the disease is coronary artery disorder.